Home › Mga Employer › Prime Medicine, Inc.
Prime Medicine, Inc.: Mga sahod ng H-1B at sponsorship
Isinampa ng Prime Medicine, Inc. ang 32 labor condition applications para sa H-1B at kaugnay na visa sa mga fiscal year na 2023–2026; sertipikado: 32. Median offered salary: $114,425.
Mga Aplikasyon (LCAs)32
Sertipikado32
Address ng employerCambridge, MA
Employer na nakadepende sa H-1BHindi
Median na sahod na iminungkahi$114,425
Gitnang bahagi ng mga sahod$98,645–$132,288
Ika-10 hanggang ika-90 percentil$80,000–$165,000
Nag-sponsor ba ang Prime Medicine, Inc. ng mga visa na H-1B?
Isinampa ng Prime Medicine, Inc. ang 32 labor condition applications sa mga fiscal year na 2023–2026, ang pinakabago ay isinampa noong Ene 23, 2026. Ang LCA ay ang unang hakbang ng isang petisyong H-1B, kaya ang employer ay nag-sponsor o naghanda na mag-sponsor ng mga manggagawang H-1B; hindi nito ginagarantiyahan ang sponsorship para sa anumang partikular na trabaho. Tingnan ang sariling listahan ng trabaho ng employer.
Mga sahod ayon sa titulo ng trabaho
| Titulo ng Trabaho | LCAs | Median na sahod |
|---|---|---|
| Senior Scientist I | 4 | $100,000 |
| Senior Associate Scientist I | 2 | $88,000 |
| Assoc. Scientist II, Analytical Development & Biochemistry | 2 | $78,552 |
| Dir. of Business Devlp, Head of Alliances & Corp. Initiative | 2 | $210,000 |
| Senior Associate Scientist | 1 | $136,000 |
| Sr. Assoc. Sci. I, Liver Gene-Editing Therapeutic Discovery | 1 | $86,550 |
| Scientist II, Ophthalmology & Cell/Molecular Bio | 1 | $78,000 |
| Sci. I, Neuromuscular Prog. Cell/Molecular Bio | 1 | $106,420 |
| Scientist I, Ex-Vivo Gene-Editing Process Development | 1 | $116,250 |
| Senior Scientist I, Off-target Biology | 1 | $110,000 |
| Scientist I, mRNA Technologies/Chemistry | 1 | $114,425 |
| Scientist I, LNP Formulation | 1 | $118,335 |
| Senior Scientist I, LNP Formulation | 1 | $118,335 |
| Associate Scientist II, BA Drug Metabolism & DMPK | 1 | $80,000 |
| Scientist I, Hematology and Immunology | 1 | $131,955 |
| Senior Scientist I, Oligonucleotide Chemistry | 1 | $165,000 |
| Scientist II, Oligonucleotide Chemistry | 1 | $140,000 |
| Senior Associate Scientist II, Biology “ Liver and Metabolic | 1 | $126,270 |
| Senior Associate Scientist II, Ex Vivo Lead Liaison, NHP PD | 1 | $113,850 |
| Senior Associate Scientist I, Hematology and Immunology | 1 | $97,290 |
| Scientist II - mRNA Chemistry | 1 | $132,622 |
| Associate Scientist II, Screening Platform and Technology | 1 | $82,800 |
| Senior Associate Scientist II, Prime Editing Platform | 1 | $113,850 |
| Senior Scientist I, Hematology and Immunology | 1 | $167,918 |
| Senior Engineer II, mRNA Process Development | 1 | $160,000 |
| Senior Associate Scientist II, mRNA Process Development | 1 | $124,500 |
Mga aplikasyon ayon sa fiscal year
| Piskal na taon | LCAs | Median na sahod |
|---|---|---|
| FY2023 | 11 | $106,420 |
| FY2024 | 12 | $131,125 |
| FY2025 | 7 | $113,850 |
| FY2026 | 2 | $142,250 |
Antas ng prevailing wage
- Antas I (pasukan)13%
- Antas II (kwalipikado)52%
- Antas III (may karanasan)23%
- Antas IV (ganap na kompetente)13%
Itinakda ng Department of Labor ang apat na antas ng prevailing wage para sa bawat okupasyon at lugar, mula Level I (entry) hanggang Level IV (fully competent). Pinipili ng employer ang antas na tumutugma sa mga kinakailangan ng trabaho.
Kung saan naroroon ang mga trabaho
Mga Okupasyon
- Molecular and Cellular Biologists13
- Biochemists and Biophysicists11
- Bioengineers and Biomedical Engineers2
- Chemists2
- Natural Sciences Managers2
- Biological Technicians1
- Chemical Engineers1
Pinakabagong aplikasyon
| Titulo ng Trabaho | Batayang sahod | Lokasyon | Isumite | Petsa ng Simula | Status |
|---|---|---|---|---|---|
| Senior Associate Scientist II, mRNA Process Development | $124,500 Antas II | Cambridge, MA | Ene 23, 2026 | Abr 10, 2026 | Sertipikado |
| Senior Engineer II, mRNA Process Development | $160,000 Antas IV | Cambridge, MA | Dis 19, 2025 | Mar 27, 2026 | Sertipikado |
| Senior Scientist I, Hematology and Immunology | $167,918 Antas IV | Cambridge, MA | Ago 4, 2025 | Set 6, 2025 | Sertipikado |
| Senior Associate Scientist II, Ex Vivo Lead Liaison, NHP PD | $113,850 Antas II | Cambridge, MA | Hun 11, 2025 | Nob 14, 2025 | Sertipikado |
| Scientist II - mRNA Chemistry | $132,622 Antas II | Watertown, MA | Abr 25, 2025 | Okt 1, 2025 | Sertipikado |
| Senior Associate Scientist I, Hematology and Immunology | $97,290 Antas II | Cambridge, MA | Abr 25, 2025 | Okt 1, 2025 | Sertipikado |
| Senior Associate Scientist II, Prime Editing Platform | $113,850 Antas II | Cambridge, MA | Abr 25, 2025 | Okt 1, 2025 | Sertipikado |
| Associate Scientist II, Screening Platform and Technology | $82,800 Antas II | Cambridge, MA | Abr 25, 2025 | Okt 1, 2025 | Sertipikado |
| Senior Associate Scientist II, Biology “ Liver and Metabolic | $126,270 Antas II | Cambridge, MA | Mar 11, 2025 | Ago 1, 2025 | Sertipikado |
| Scientist II, Oligonucleotide Chemistry | $140,000 Antas II | Watertown, MA | Ago 28, 2024 | Okt 1, 2024 | Sertipikado |
| Dir. of Business Devlp, Head of Alliances & Corp. Initiative | $210,000 Antas II | Cambridge, MA | Ago 21, 2024 | Set 23, 2024 | Sertipikado |
| Dir. of Business Devlp, Head of Alliances & Corp. Initiative | $210,000 Antas II | Cambridge, MA | Ago 6, 2024 | Set 23, 2024 | Sertipikado, pagkatapos ay tinanggal |
| Senior Scientist I, Oligonucleotide Chemistry | $165,000 Antas III | Watertown, MA | May 1, 2024 | Okt 1, 2024 | Sertipikado |
| Scientist I, Hematology and Immunology | $131,955 Antas III | Cambridge, MA | May 1, 2024 | Okt 1, 2024 | Sertipikado |
| Associate Scientist II, BA Drug Metabolism & DMPK | $80,000 Antas I | Cambridge, MA | May 1, 2024 | Okt 1, 2024 | Sertipikado |
| Senior Scientist I, LNP Formulation | $118,335–$159,999 Antas III | Cambridge, MA | Ene 2, 2024 | May 17, 2024 | Sertipikado |
| Scientist I, LNP Formulation | $118,335–$159,999 Antas III | Cambridge, MA | Nob 30, 2023 | May 17, 2024 | Sertipikado |
| Senior Scientist I | $131,125–$159,999 Antas IV | Cambridge, MA | Nob 14, 2023 | Abr 5, 2024 | Sertipikado |
| Senior Scientist I | $133,328–$171,434 part-time · Antas II | Cambridge, MA | Nob 1, 2023 | Nob 13, 2023 | Sertipikado |
| Senior Scientist I | $100,000–$150,000 Antas II | Cambridge, MA | Okt 23, 2023 | Nob 13, 2023 | Sertipikado |
| Senior Scientist I | $100,000–$150,000 Antas II | Cambridge, MA | Okt 23, 2023 | Nob 8, 2023 | Sertipikado |
| Scientist I, mRNA Technologies/Chemistry | $114,425–$122,000 Antas III | Cambridge, MA | Ago 30, 2023 | Okt 1, 2023 | Sertipikado |
| Assoc. Scientist II, Analytical Development & Biochemistry | $75,000–$102,000 | Cambridge, MA | Hun 15, 2023 | Okt 1, 2023 | Sertipikado |
| Assoc. Scientist II, Analytical Development & Biochemistry | $82,105–$102,000 Antas I | Cambridge, MA | Hun 15, 2023 | Okt 1, 2023 | Sertipikado |
| Sr. Assoc. Sci. I, Liver Gene-Editing Therapeutic Discovery | $86,550–$106,419 Antas II | Cambridge, MA | Hun 11, 2023 | Okt 1, 2023 | Sertipikado |
| Scientist II, Ophthalmology & Cell/Molecular Bio | $78,000–$102,000 Antas I | Cambridge, MA | Hun 11, 2023 | Hun 26, 2023 | Sertipikado |
| Sci. I, Neuromuscular Prog. Cell/Molecular Bio | $106,420–$130,095 Antas III | Cambridge, MA | Hun 2, 2023 | Okt 1, 2023 | Sertipikado |
| Scientist I, Ex-Vivo Gene-Editing Process Development | $116,250–$125,000 Antas III | Cambridge, MA | May 26, 2023 | Okt 1, 2023 | Sertipikado |
| Senior Scientist I, Off-target Biology | $110,000–$160,000 Antas II | Cambridge, MA | Abr 24, 2023 | May 15, 2023 | Sertipikado |
| Senior Associate Scientist | $136,000–$150,000 Antas IV | Cambridge, MA | Mar 9, 2023 | Mar 27, 2023 | Sertipikado |
| Senior Associate Scientist I | $109,000–$120,000 Antas II | Cambridge, MA | Mar 7, 2023 | Abr 10, 2023 | Sertipikado |
| Senior Associate Scientist I | $67,000–$110,000 Antas I | Cambridge, MA | Nob 8, 2022 | Nob 14, 2022 | Sertipikado |
Ang mga sahod ay ang mababang dulo ng alok na sweldo sa bawat aplikasyon, na isinalin sa taunang halaga; ginagamit lamang ng istatistika ang mga sertipikadong full-time na aplikasyon. Ang LCA ay hindi pag-apruba ng visa at maaaring saklawin ng isang LCA ang ilang posisyon. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (pinakabagong desisyon: Hun 30, 2026).